Skip to main content
Log in

Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver

  • Magnetic Resonance
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To investigate the utility of diffusion-weighted imaging (DWI), apparent diffusion coefficient (ADC) and the correlation with hepatobiliary phase (delayed phase imaging, DPI) findings in the differentiation of cirrhotic hepatocellular nodules.

Methods

Forty-three patients with 53 pathology-proven nodules (29 hepatocellular carcinomas (HCCs), 13 high-grade (HGDNs) and 11 low-grade dysplastic nodules (LGDNs); mean size 2.17 cm, range 1–4 cm), who underwent liver MRI with DWI and DPI sequences, were retrospectively reviewed. Lesions were classified as hypointense, isointense, or hyperintense relative to the adjacent liver parenchyma. ADC of each nodule, of the surrounding parenchyma, and lesion-to-liver ratio were calculated.

Results

Hyperintensity versus iso/hypointensity on DWI, hypointensity versus iso/hyperintensity on DPI, and the mean lesion-to-liver ratio showed a statistically significant difference both between HCCs versus DNs and between “HCCs + HGDNs” versus LGDNs (p < 0.05); sensitivity, specificity, and accuracy for the diagnosis of “HCCs + HGDNs” were 96.8 %, 100 %, 97.4 % respectively when combining hyperintensity on DWI and hypointensity on DPI, and 90.9 %, 81.0 %, 83.6 % respectively when lesion-to-liver ratio was <0.95.

Conclusions

Hyperintensity on DWI, especially in association with hypointensity on DPI, and low lesion-to-liver ratios should raise the suspicion of HCC, or at least of HGDN, thus helping the characterization of atypically enhancing lesions.

Key points

Usefulness of DWI and ADC is shown in differential diagnosis of cirrhotic nodules.

Correlation of DWI with DPI improves differential diagnosis of cirrhotic nodules.

Characterization of atypically enhancing lesions becomes more confident.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

DNs:

dysplastic nodules

DPI:

delayed phase imaging

FLLs:

focal liver lesions

SI:

signal intensity

FNB:

fine-needle biopsy

CNB:

core-needle biopsy

HGDNs:

high-grade dysplastic nodules

LGDNs:

low-grade dysplastic nodules

PPV:

positive predictive value

NPV:

negative predictive value

FN:

false negative

FP:

false positive

References

  1. Bruix J, Sherman M, American Association for the Study of Liver Diseases (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

    Article  PubMed Central  PubMed  Google Scholar 

  2. Jonas S, Bechstein WO, Steinmüller T et al (2001) Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33:1080–1086

    Article  CAS  PubMed  Google Scholar 

  3. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943

    Google Scholar 

  4. Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 244:898–906

    Article  PubMed  Google Scholar 

  5. Forner A, Vilana R, Ayuso C et al (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47:97–104

    Article  PubMed  Google Scholar 

  6. Krinsky GA, Lee VS, Theise ND et al (2001) Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 219:445–454

    Article  CAS  PubMed  Google Scholar 

  7. Kim YK, Lee JM, Kim CS (2004) Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 14:5–13

    Article  PubMed  Google Scholar 

  8. Pirovano G, Vanzulli A, Marti-Bonmati L et al (2000) Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions. AJR Am J Roentgenol 175:1111–1120

    Article  CAS  PubMed  Google Scholar 

  9. Parikh T, Drew SJ, Lee VS et al (2008) Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 246:812–822

    Article  PubMed  Google Scholar 

  10. Le Moigne F, Durieux M, Bancel B et al (2012) Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver. Magn Reson Imaging 30:656–665

    Article  PubMed  Google Scholar 

  11. Piana G, Trinquart L, Meskine N, Barrau V, Beers BV, Vilgrain V (2011) New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases. J Hepatol 55:126–132

    Article  PubMed  Google Scholar 

  12. Xu PJ, Yan FH, Wang JH, Lin J, Ji Y (2009) Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. J Magn Reson Imaging 29:341–349

    Article  PubMed  Google Scholar 

  13. Vandecaveye V, De Keyzer F, Verslype C et al (2009) Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur Radiol 19:2456–2466

    Article  PubMed  Google Scholar 

  14. Park MS, Kim S, Patel J et al (2012) Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients. Hepatology 56:140–148

    Article  PubMed  Google Scholar 

  15. Kim YK, Kim CS, Han YM, Lee YH (2011) Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial? Clin Radiol 66:489–496

    Article  PubMed  Google Scholar 

  16. Bruegel M, Holzapfel K, Gaa J et al (2008) Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 18:477–485

    Article  PubMed  Google Scholar 

  17. Sandrasegaran K, Tahir B, Patel A et al (2013) The usefulness of diffusion-weighted imaging in the characterization of liver lesions in patients with cirrhosis. Clin Radiol 68:708–715

    Article  CAS  PubMed  Google Scholar 

  18. Filipe JP, Curvo-Semedo L, Casalta-Lopes J, Marques MC, Caseiro-Alves F (2013) Diffusion-weighted imaging of the liver: usefulness of ADC values in the differential diagnosis of focal lesions and effect of ROI methods on ADC measurements. MAGMA 26:303–312

    Article  CAS  PubMed  Google Scholar 

  19. Lim KS (2014) Diffusion-weighted MRI of hepatocellular carcinoma in cirrhosis. Clin Radiol 69:1–10

    Article  CAS  PubMed  Google Scholar 

  20. Taouli B, Tolia AJ, Losada M et al (2007) Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 189:799–806

    Article  PubMed  Google Scholar 

  21. Guiu B, Cercueil JP (2011) Liver diffusion-weighted MR imaging: the tower of Babel? Eur Radiol 21:463–467

    Article  PubMed  Google Scholar 

  22. International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983–993

    Article  Google Scholar 

  23. International Consensus Group for Hepatocellular Neoplasia (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 49:658–664

    Article  Google Scholar 

  24. Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiology 1:43–46

    Article  CAS  PubMed  Google Scholar 

  25. Perneger TV (1998) What’s wrong with Bonferroni adjustments. BMJ 316:1236–1238

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ (2010) Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. J Comput Assist Tomogr 34:506–512

    Article  PubMed  Google Scholar 

  27. Holzapfel K, Bruegel M, Eiber M et al (2010) Characterization of small (≤10 mm) focal liver lesions: value of respiratory-triggered echo-planar diffusion-weighted MR imaging. Eur J Radiol 76:89–95

    Article  PubMed  Google Scholar 

  28. Gourtsoyianni S, Papanikolaou N, Yarmenitis S, Maris T, Karantanas A, Gourtsoyiannis N (2008) Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 18:486–492

    Article  PubMed  Google Scholar 

  29. Kobayashi M, Ikeda K, Hosaka T et al (2006) Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis. Cancer 106:636–647

    Article  PubMed  Google Scholar 

  30. Borzio M, Fargion S, Borzio F et al (2003) Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 39:208–214

    Article  PubMed  Google Scholar 

  31. Longchampt E, Patriarche C, Fabre M (2000) Accuracy of cytology vs. microbiopsy for the diagnosis of well-differentiated hepatocellular carcinoma and macroregenerative nodule. Definition of standardized criteria from a study of 100 cases. Acta Cytol 44:515–523

    Article  CAS  PubMed  Google Scholar 

  32. Sersté T, Barrau V, Ozenne V et al (2012) Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. Hepatology 55:800–806

    Article  PubMed  Google Scholar 

  33. Gatto A, De Gaetano AM, Giuga M et al (2013) Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging. Abdom Imaging 38:736–744

    Article  CAS  PubMed  Google Scholar 

  34. Lee MH, Kim SH, Park MJ, Park CK, Rhim H (2011) Gadoxetic acid–enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. AJR Am J Roentgenol 197:W868–W875

    Article  PubMed  Google Scholar 

  35. Di Martino M, Di Miscio R, De Filippis G et al (2013) Detection of small (≤2 cm) HCC in cirrhotic patients: added value of diffusion MR-imaging. Abdom Imaging 38:1254–1262

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The scientific guarantor of this publication is Lorenzo Bonomo. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. One of the authors has significant statistical expertise. Institutional Review Board approval was obtained. Written informed consent was not required for this study because of its retrospective nature. Methodology: retrospective, observational, performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Riccardo Inchingolo.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inchingolo, R., De Gaetano, A.M., Curione, D. et al. Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver. Eur Radiol 25, 1087–1096 (2015). https://doi.org/10.1007/s00330-014-3500-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-014-3500-7

Keywords

Navigation